Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...

Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with platinum-resistant ovarian cancer.

The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated recurrent low-grade serous ovarian cancer.

The Hormel Institute, University of Minnesota, along with Nu-Tek BioSciences have announced the inaugural Ribbon Research Open, a charity golf tournament taking place in Austin this August. Set ...